Department of Clinical Infection Microbiology & Immunology,
Institute of Infection & Global Health,
Department of Clinical Infection Microbiology & Immunology, Institute of Infection & Global Health
Aras Kadioglu has not added Biography.
If you are Aras Kadioglu and would like to personalize this page please email our Author Liaison for assistance.
Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection.
Infection and immunity Mar, 2002 | Pubmed ID: 11854243
Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type.
Infection and immunity Jun, 2002 | Pubmed ID: 12010976
Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin.
Infection and immunity Apr, 2003 | Pubmed ID: 12654795
The MicAB two-component signaling system is involved in virulence of Streptococcus pneumoniae.
Infection and immunity Nov, 2003 | Pubmed ID: 14573696
Binding and agglutination of Streptococcus pneumoniae by human surfactant protein D (SP-D) vary between strains, but SP-D fails to enhance killing by neutrophils.
Infection and immunity Feb, 2004 | Pubmed ID: 14742512
The innate immune response to pneumococcal lung infection: the untold story.
Trends in immunology Mar, 2004 | Pubmed ID: 15036042
Protein serine/threonine kinase StkP positively controls virulence and competence in Streptococcus pneumoniae.
Infection and immunity Apr, 2004 | Pubmed ID: 15039376
CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.
Infection and immunity May, 2004 | Pubmed ID: 15102777
Identification of a detrimental role for NK cells in pneumococcal pneumonia and sepsis in immunocompromised hosts.
Microbes and infection / Institut Pasteur May, 2005 | Pubmed ID: 15893495
Susceptibility and resistance to pneumococcal disease in mice.
Briefings in functional genomics & proteomics Nov, 2005 | Pubmed ID: 16420749
Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis.
Infection and immunity Jul, 2006 | Pubmed ID: 16790774
Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis.
Molecular microbiology Sep, 2006 | Pubmed ID: 16925554
The cathepsin B inhibitor, z-FA-FMK, inhibits human T cell proliferation in vitro and modulates host response to pneumococcal infection in vivo.
Journal of immunology (Baltimore, Md. : 1950) Sep, 2006 | Pubmed ID: 16951345
MobilomeFINDER: web-based tools for in silico and experimental discovery of bacterial genomic islands.
Nucleic acids research Jul, 2007 | Pubmed ID: 17537813
The ability to utilize mucin affects the regulation of virulence gene expression in Streptococcus pneumoniae.
FEMS microbiology letters Jan, 2008 | Pubmed ID: 18053067
The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease.
Nature reviews. Microbiology Apr, 2008 | Pubmed ID: 18340341
Increased TNF expression in CD43++ murine blood monocytes.
Immunology letters Jun, 2008 | Pubmed ID: 18468696
Sialic acid: a preventable signal for pneumococcal biofilm formation, colonization, and invasion of the host.
The Journal of infectious diseases May, 2009 | Pubmed ID: 19392624
Macrophages from BALB/c and CBA/Ca mice differ in their cellular responses to Streptococcus pneumoniae.
Journal of leukocyte biology Apr, 2010 | Pubmed ID: 20028774
The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease.
Immunobiology Apr, 2010 | Pubmed ID: 20071053
Pathogenicity islands PAPI-1 and PAPI-2 contribute individually and synergistically to the virulence of Pseudomonas aeruginosa strain PA14.
Infection and immunity Apr, 2010 | Pubmed ID: 20123716
Human lung mast cells mediate pneumococcal cell death in response to activation by pneumolysin.
Journal of immunology (Baltimore, Md. : 1950) Jun, 2010 | Pubmed ID: 20483738
A subtype of a Pseudomonas aeruginosa cystic fibrosis epidemic strain exhibits enhanced virulence in a murine model of acute respiratory infection.
The Journal of infectious diseases Sep, 2010 | Pubmed ID: 20704484
Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4.
PLoS pathogens , 2010 | Pubmed ID: 21085613
The integrins Mac-1 and alpha4beta1 perform crucial roles in neutrophil and T cell recruitment to lungs during Streptococcus pneumoniae infection.
Journal of immunology (Baltimore, Md. : 1950) May, 2011 | Pubmed ID: 21460207
Streptococcus pyogenes antigen I/II-family polypeptide AspA shows differential ligand-binding properties and mediates biofilm formation.
Molecular microbiology Aug, 2011 | Pubmed ID: 21736640
Sex-based differences in susceptibility to respiratory and systemic pneumococcal disease in mice.
The Journal of infectious diseases Dec, 2011 | Pubmed ID: 22021621
Absence of the lectin activation pathway of complement does not increase susceptibility to Pseudomonas aeruginosa infections.
Immunobiology Feb, 2012 | Pubmed ID: 22070931
Persistence of pneumolysin in the cerebrospinal fluid of patients with pneumococcal meningitis is associated with mortality.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Mar, 2012 | Pubmed ID: 22238165
Capsule type of Streptococcus pneumoniae determines growth phenotype.
PLoS pathogens , 2012 | Pubmed ID: 22412375
P4-mediated antibody therapy in an acute model of invasive pneumococcal disease.
The Journal of infectious diseases May, 2012 | Pubmed ID: 22457294
T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice.
PLoS pathogens , 2012 | Pubmed ID: 22563306
Nicotinamide nucleotide transhydrogenase (NNT) acts as a novel modulator of macrophage inflammatory responses.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Aug, 2012 | Pubmed ID: 22593545
Gene expression in fungi.
IMA fungus Jun, 2011 | Pubmed ID: 22679585
The lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infection.
PLoS pathogens , 2012 | Pubmed ID: 22792067
Nasopharyngeal carriage with Streptococcus pneumoniae augments the immunizing effect of pneumolysin toxoid B.
The Journal of allergy and clinical immunology Dec, 2012 | Pubmed ID: 23260752
Controlled Human Infection and Re-Challenge with Streptococcus Pneumoniae Reveals the Protective Efficacy of Carriage in Healthy Adults.
American journal of respiratory and critical care medicine Jan, 2013 | Pubmed ID: 23370916
The AgI/II family adhesin AspA is required for respiratory infection by Streptococcus pyogenes.
PloS one , 2013 | Pubmed ID: 23638083
Immunoactivating peptide p4 augments alveolar macrophage phagocytosis in two diverse human populations.
Antimicrobial agents and chemotherapy Sep, 2013 | Pubmed ID: 23817378
The pneumococcal polysaccharide capsule and pneumolysin differentially affect CXCL8 and IL-6 release from cells of the upper and lower respiratory tract.
PloS one , 2014 | Pubmed ID: 24664110
Streptococcus pneumoniae detects and responds to foreign bacterial peptide fragments in its environment.
Open biology Apr, 2014 | Pubmed ID: 24718598
Density and duration of pneumococcal carriage is maintained by transforming growth factor β1 and T regulatory cells.
American journal of respiratory and critical care medicine May, 2014 | Pubmed ID: 24749506
The B lymphocyte differentiation factor (BAFF) is expressed in the airways of children with CF and in lungs of mice infected with Pseudomonas aeruginosa.
PloS one , 2014 | Pubmed ID: 24847941
Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs.
Nature communications Sep, 2014 | Pubmed ID: 25179232
Ca²⁺-dependent repair of pneumolysin pores: A new paradigm for host cellular defense against bacterial pore-forming toxins.
Biochimica et biophysica acta Sep, 2015 | Pubmed ID: 25219550
Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice.
Nature biotechnology Jan, 2015 | Pubmed ID: 25362245
Circulating Pneumolysin Is a Potent Inducer of Cardiac Injury during Pneumococcal Infection.
PLoS pathogens May, 2015 | Pubmed ID: 25973949
Alternatives to antibiotics-a pipeline portfolio review.
The Lancet. Infectious diseases Feb, 2016 | Pubmed ID: 26795692
Augmented Passive Immunotherapy with P4 Peptide Improves Phagocyte Activity in Severe Sepsis.
Shock (Augusta, Ga.) Dec, 2016 | Pubmed ID: 27488089
Recombination in Streptococcus pneumoniae Lineages Increase with Carriage Duration and Size of the Polysaccharide Capsule.
mBio Sep, 2016 | Pubmed ID: 27677790
The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1.
Vaccine Feb, 2017 | Pubmed ID: 28081968
Phage therapy is highly effective against chronic lung infections with .
Thorax Jul, 2017 | Pubmed ID: 28265031
Epidemiological and Molecular Characterization of an Invasive Group A Streptococcus 32.2 Outbreak.
Journal of clinical microbiology Jun, 2017 | Pubmed ID: 28356413
The accessory Sec system (SecY2A2) in Streptococcus pneumoniae is involved in export of pneumolysin toxin, adhesion and biofilm formation.
Microbes and infection , 2017 | Pubmed ID: 28456649
Comparative Genomic Analysis and In Vivo Modeling of Streptococcus pneumoniae ST3081 and ST618 Isolates Reveal Key Genetic and Phenotypic Differences Contributing to Clonal Replacement of Serotype 1 in The Gambia.
The Journal of infectious diseases Dec, 2017 | Pubmed ID: 28968897
Dairy Heifers Naturally Exposed to Fasciola hepatica Develop a Type 2 Immune Response and Concomitant Suppression of Leukocyte Proliferation.
Infection and immunity Jan, 2018 | Pubmed ID: 28993458
E-cigarette vapour enhances pneumococcal adherence to airway epithelial cells.
The European respiratory journal Feb, 2018 | Pubmed ID: 29437942
Erratum for Graham-Brown et al., "Dairy Heifers Naturally Exposed to Fasciola hepatica Develop a Type 2 Immune Response and Concomitant Suppression of Leukocyte Proliferation".
Infection and immunity Jun, 2018 | Pubmed ID: 29789434
Multiple communication mechanisms between sensor kinases are crucial for virulence in Pseudomonas aeruginosa.
Nature communications Jun, 2018 | Pubmed ID: 29880803
Erratum for Cornick et al., "Epidemiological and Molecular Characterization of an Invasive Group A Streptococcus 32.2 Outbreak".
Journal of clinical microbiology Sep, 2018 | Pubmed ID: 30150291
Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival.
Nature microbiology Jan, 2019 | Pubmed ID: 30420782
Early Signals of Vaccine-driven Perturbation Seen in Pneumococcal Carriage Population Genomic Data.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Mar, 2020 | Pubmed ID: 31094423
Impaired Alanine Transport or Exposure to d-Cycloserine Increases the Susceptibility of MRSA to β-lactam Antibiotics.
The Journal of infectious diseases Mar, 2020 | Pubmed ID: 31628459
IL-35 is critical in suppressing superantigenic Staphylococcus aureus-driven inflammatory Th17 responses in human nasopharynx-associated lymphoid tissue.
Mucosal immunology May, 2020 | Pubmed ID: 31896761
Exposure to diesel exhaust particles increases susceptibility to invasive pneumococcal disease.
The Journal of allergy and clinical immunology Apr, 2020 | Pubmed ID: 31983527
Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin.
Nature communications Apr, 2020 | Pubmed ID: 32312961
Influenza-like illness is associated with high pneumococcal carriage density in Malawian children.
The Journal of infection Oct, 2020 | Pubmed ID: 32711042
Bacterial genome-wide association study of hyper-virulent pneumococcal serotype 1 identifies genetic variation associated with neurotropism.
Communications biology Oct, 2020 | Pubmed ID: 33033372
Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity.
Scientific reports Oct, 2020 | Pubmed ID: 33057054
Lower Density and Shorter Duration of Nasopharyngeal Carriage by Pneumococcal Serotype 1 (ST217) May Explain Its Increased Invasiveness over Other Serotypes.
mBio Dec, 2020 | Pubmed ID: 33293378
Author Correction: Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity.
Scientific reports Mar, 2021 | Pubmed ID: 33731755
Intestinal helminth co-infection is an unrecognised risk factor for increased pneumococcal carriage density and invasive disease.
Scientific reports Mar, 2021 | Pubmed ID: 33772094
Serotype 1 pneumococcus: epidemiology, genomics, and disease mechanisms.
Trends in microbiology Jun, 2022 | Pubmed ID: 34949516
Author Correction: Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity.
Scientific reports Mar, 2022 | Pubmed ID: 35332175
Structure-Based Discovery of Lipoteichoic Acid Synthase Inhibitors.
Journal of chemical information and modeling May, 2022 | Pubmed ID: 35533315
Mechanistic Insights into the Impact of Air Pollution on Pneumococcal Pathogenesis and Transmission.
American journal of respiratory and critical care medicine Nov, 2022 | Pubmed ID: 35649181
Selection of in a murine nasopharyngeal colonization model.
Frontiers in cellular and infection microbiology , 2022 | Pubmed ID: 35992161
Exploiting lung adaptation and phage steering to clear pan-resistant Pseudomonas aeruginosa infections in vivo.
Nature communications Feb, 2024 | Pubmed ID: 38378698
Intranasal administration of DSM 32444 spores: safety and tolerability.
Journal of medical microbiology Jul, 2024 | Pubmed ID: 38963177
Spir2; a novel QTL on chromosome 4 contributes to susceptibility to pneumococcal infection in mice.
BMC genomics Apr, 2013 | Pubmed ID: 23577770
Neutrophil IL-1β processing induced by pneumolysin is mediated by the NLRP3/ASC inflammasome and caspase-1 activation and is dependent on K+ efflux.
Journal of immunology (Baltimore, Md. : 1950) Feb, 2015 | Pubmed ID: 25609842
Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients.
Journal of aerosol medicine and pulmonary drug delivery Oct, 2015 | Pubmed ID: 25714328
Airborne dust and high temperatures are risk factors for invasive bacterial disease.
The Journal of allergy and clinical immunology Mar, 2017 | Pubmed ID: 27523432
Redeploying β-Lactam Antibiotics as a Novel Antivirulence Strategy for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections.
The Journal of infectious diseases Jan, 2017 | Pubmed ID: 28077586
Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection.
Scientific reports Sep, 2021 | Pubmed ID: 34561464
Comparative Genomics of Disease and Carriage Serotype 1 Pneumococci.
Genome biology and evolution Apr, 2022 | Pubmed ID: 35439297
Underground railway particulate matter and susceptibility to pneumococcal infection.
EBioMedicine Jun, 2022 | Pubmed ID: 35598440
Pseudomonas aeruginosa utilizes the host-derived polyamine spermidine to facilitate antimicrobial tolerance.
JCI insight Nov, 2022 | Pubmed ID: 36194492
The LytSR two-component regulatory system promotes vaginal colonization and virulence .
Microbiology spectrum Oct, 2024 | Pubmed ID: 39400158
Jenna F. Gritzfeld1,
Angie D. Wright1,2,3,
Andrea M. Collins1,2,4,
Shaun H. Pennington1,
Adam K.A. Wright5,
Aras Kadioglu6,
Daniela M. Ferreira1,
Stephen B. Gordon1
1Respiratory Infection Group, Liverpool School of Tropical Medicine,
2Royal Liverpool and Broadgreen, University Hospital Trust,
3, Comprehensive Local Research Network,
4NIHR Biomedical Research Centre in Microbial Diseases, Royal Liverpool and Broadgreen University Hospitals NHS Trust,
5Institute of Lung Health, Respiratory Biomedical Unit, University Hospitals of Leicester NHS Trust & University of Leicester,
6Department of Clinical Infection Microbiology & Immunology, Institute of Infection & Global Health, University of Liverpool
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados